Actively Recruiting
Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients
Led by Washington University School of Medicine · Updated on 2025-10-30
112
Participants Needed
1
Research Sites
107 weeks
Total Duration
On this page
Sponsors
W
Washington University School of Medicine
Lead Sponsor
U
United States Department of Defense
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study evaluates the feasibility and preliminary effects of precision tobacco treatment, compared to usual care, on promoting tobacco treatment in oncology patients and providers in the oncology care setting. The precision treatment intervention includes personalized tobacco treatment recommendations using the patient's clinical, genetic, and biomarker information. This intervention may increase patient receipt of tobacco treatment, patient medication use, and patient smoking abstinence at 6 months.
CONDITIONS
Official Title
Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient at participating clinic
- Age 18 to 89 years
- Current smoking with an average of at least 5 cigarettes per day
- Can speak and understand English
- Willing to consider medication to help reduce craving or smoking such as nicotine patch, lozenge, or varenicline
You will not qualify if you...
- Active use of smoking cessation medication within the past 30 days
- Receipt of smoking cessation medication or prescription within the past 30 days
- Contraindications for nicotine replacement therapy or varenicline, including allergic reactions, current heart problems, or pregnancy
- Deemed ineligible for participation by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110
Actively Recruiting
Research Team
L
Li-Shiun Chen, ScD, M.D., MPH
CONTACT
T
Theodore Thomas, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here